,19 In this context, our results suggest that progressively increasing PD-L1 thresholds should be explored as predictors of immunotherapy efficacy also among patients with early stage lung cancer, to inform the design of perioperative trials with immune checkpoint blockade. This evidence concerns the gene CD274 and lung cancer.